PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Significance: The liver plays crucial roles in the control of glucose homeostasis during the fast-feeding cycle. It responds to insulin and glucagon to either store or provide glucose to other organs. Insulin resistance is a hallmark of metabolic diseases such as type 2 diabetes and nonalcoholic fatty liver disease. Associations have been made between low hepatic levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1A) and hepatic insulin resistance, but underlying mechanisms are elusive. We show that PGC1A controls the hepatic ratio of Insulin Receptor Substrates 1 (IRS1) and IRS2 expression, crucial for defining the precise insulin signal in hepatocytes to respond to fasting and feeding. Importantly, PGC1A is key for insulin-mediated suppression of hepatic glucose production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that IRS1 and IRS2 have distinct roles in regulating hepatic lipid metabolism [20,30,97].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · cited 1×
“In metabolic disorders such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), the liver becomes resistant to the actions of insulin, even in a hyperinsulinemic context (3).”
BackgroundControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 3×
“Moreover, PGC1A knockdown decreased basal and glucagon-induced G6pc and Pepck mRNA, as previously described (5), as well as Hsl, another PGC1A target (20) not regulated by glucagon (SI Appendix, Fig.”
BackgroundTranscriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666 · cited 1×
“Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1A) is a transcriptional coactivator within a family that includes two other members, peroxisome proliferatoractivated receptor gamma coactivator 1-beta (PGC1B) and peroxisome proliferator-activated receptor gamma coactivatorrelated protein 1 (PP…”
BackgroundmTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440 · cited 2×
“To determine whether TCF4 or CREB were necessary for the glucagon/PGC1A/IRS2 axis, we assessed the ability of glucagon and PGC1A to induce IRS2 in the presence of dominantnegative TCF4 (31) or CREB (21).”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · cited 2×
“Since various proteins can directly or indirectly regulate phosphorylation of AKT in response to insulin (2), we hypothesized that, as a transcriptional coactivator, PGC1A might differentially control expression of one or many of these intermediates.”
BackgroundLKB1 and AMP-activated protein kinase control of mTOR signalling and growth
Shaw, R. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01972.x · Cited by 644 · cited 1×
“Further studies are warranted to unravel mechanistic connections between PGC1A and mTOR, which could also be complicated by the effects of PGC1A on metabolites sensed by AMPK and mTOR (36).”
Background
Cited by
PGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“Indeed mice with liverspecific mutations in the insulin receptor present high PGC-1α levels in the liver, which demonstrates the key role of insulin as a suppressor of PGC-1α [45, 49].”
BackgroundMechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Silva Rosa, S. C., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 240
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Insulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 212
“Fasting and exercise also induce the CREB CRTC2 transcriptional complex through glucagon signaling; this increases expression of gluconeogenic genes as well as IRS2 [129].”
BackgroundInfluentialSingh, A., Shadangi, S., Gupta, P. K., & Rana, S. (2025) · Comprehensive Physiology · doi:10.1002/cph4.70003 · Cited by 163
PARPs in lipid metabolism and related diseases
Szántó, M., Gupte, R., Kraus, W. L., Pacher, P., & Bai, P. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101117 · Cited by 181
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126
“Additionally, PGC-1α induced in fasting was shown to increase the IRS2 to IRS1 ratio in hepatocytes, increasing the sensitivity for insulin-induced suppression of glucose production (Besse-Patin et al. 2019).”
BackgroundInfluentialInsulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Armandi, A., Rosso, C., Caviglia, G. P., & Bugianesi, E. (2021) · Metabolites · doi:10.3390/metabo11030155 · Cited by 126
“Recently, it has been reported that PGC-1α is able to affect IRS-1 and IRS-2 expression, impacting normal glucose homeostasis [30].”
BackgroundTruong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“When glucagon and glucocorticoids are elevated in the fasting state, expression of PGC1α is increased [29,30].”
Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
Meijnikman, A. S., Herrema, H., Scheithauer, T. P. M., Kroon, J., Nieuwdorp, M., & Groen, A. K. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100301 · Cited by 75
PGC-1α in Disease: Recent Renal Insights into a Versatile Metabolic Regulator
Chambers, J. M., & Wingert, R. A. (2020) · Cells · doi:10.3390/cells9102234 · Cited by 81
“Further, it was recently demonstrated that PGC-1α plays an important role in the hepatic response to insulin during the fasting-to-fed transition by regulating expression of upstream components of the insulinsignaling pathway [23,24].”
BackgroundMihaylova, L. V., Savova, M. S., Amirova, K. M., Balcheva-Sivenova, Z. P., Ferrante, C., Orlando, G., Wabitsch, M., & Georgiev, M. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249740 · Cited by 75
“The PGC-1α protein is of key importance for the maintenance of insulin sensitivity and mitochondrial biogenesis in both hepatic and adipose tissues and its activation leads to browning through increase in UCP1 expression [18,24,29,58].”
BackgroundFasting: From Physiology to Pathology
Tang, D., Tang, Q., Huang, W., Zhang, Y., Tian, Y., & Fu, X. (2023) · Advanced Science · doi:10.1002/advs.202204487 · Cited by 86
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance
He, S., Ryu, J., Liu, J., Luo, H., Lv, Y., Langlais, P. R., Wen, J., Dong, F., Sun, Z., Xia, W., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148545 · Cited by 75
“ coactivator 1 (Pgc1a) increased the expression of Irs2 but reduced the expression of Irs1 in 237 mouse hepatocytes (32).”
BackgroundEpigenetics of Hepatic Insulin Resistance
Maude, H., Sanchez-Cabanillas, C., & Cebola, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.681356 · Cited by 69
“PGC1a may act in part by decreasing the IRS1:IRS2 ratio, with the increased levels of IRS2 effectively amplifying the insulin-dependent suppression of gluconeogenesis (49) (Figure 2).”
BackgroundNeto, I. V. D. S., Pinto, A. P., Muñoz, V. R., Marqueti, R. D. C., Pauli, J. R., Ropelle, E. R., & da Silva, A. S. R. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101935 · Cited by 65
Chen, Y., Liu, X., Liu, Y., Li, Y., Li, D., Mei, Z., & Deng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07936-y · Cited by 64
“Activation of the AMPK/SIRT1/PGC-1 α axis enhances mitogenesis, suppresses gluconeogenesis, and promotes fatty acid oxidation, reversing lipid accumulation and IR in T2DM [80, 103].”
Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators
Ramatchandirin, B., Pearah, A., & He, L. (2023) · Life · doi:10.3390/life13020515 · Cited by 47
Kalemba, K. M., Wang, Y., Xu, H., Chiles, E. N., McMillin, S. M., Kwon, H., Su, X., & Wondisford, F. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011033 · Cited by 45
PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments
Léveillé, M., Besse‐Patin, A., Jouvet, N., Güneş, A., Sczelecki, S., Jeromson, S., Khan, N. P., Baldwin, C., Dumouchel, A., Correia, J. C., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.004 · Cited by 45
Self-citationCross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
Habegger, K. M. (2022) · Diabetes · doi:10.2337/dbi22-0002 · Cited by 44
Glucose Metabolism in Burns—What Happens?
Bădoiu, S. C., Miricescu, D., Stănescu-Spînu, I.-I., Totan, A., Badoiu, S. E., Costagliola, M., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105159 · Cited by 38
Karimi, R., Yanovich, A., Elbarbry, F., & Cleven, A. J. (2024) · Metabolites · doi:10.3390/metabo14060336 · Cited by 39
Li, Y., Wang, B., Shen, J.-D., Bai, M., & Xu, E. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1756349 · Cited by 35
“A recent study confirmed that PGC1a is involved in insulin-stimulated AKT phosphorylation (Besse-Patin et al. 2019).”
BackgroundWan, X., Zhu, X., Wang, H., Feng, Y., Zhou, W., Liu, P., Shen, W., Zhang, L., Liu, L., Li, T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902476r · Cited by 35
Friedline, R. H., Noh, H. L., Suk, S., Albusharif, M., Dağdeviren, S., Saengnipanthkul, S., Kim, B. K., Kim, A. M., Kim, L. H., TAUER, L. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49633-y · Cited by 35
Biondo, L. A., Teixeira, A. A. S., Ferreira, K. C. D. O. S., & Neto, J. C. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200122124116 · Cited by 35
Tavares, C. D. J., Aigner, S., Sharabi, K., Sathe, S., Mutlu, B., Yeo, G. W.-M., & Puigserver, P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000643117 · Cited by 33
“Although PGC-1 α has been shown to mediate part of the glucagon and fasting response (37 – 40), the complete mechanisms and targets, in particular the binding to RNAs, are not entirely understood.”
BackgroundEffects of intermittent fasting on liver physiology and metabolism in mice
Ma, J., Cheng, Y., Su, Q., Ai, W., Gong, L., Wang, Y., Li, L., Ma, Z., Pan, Q., Qiao, Z., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10382 · Cited by 32
“The liver takes up glucose and synthesizes glycogen and triglycerides following food intake, releases glucose produced by glycogenolysis or gluconeogenesis and triggers ketogenesis during fasting (23).”
InfluentialHigh Glucose Levels Promote Switch to Synthetic Vascular Smooth Muscle Cells via Lactate/GPR81
Yang, J., Gourley, G. R., Gilbertsen, A. J., Chen, C., Wang, L., Smith, K. A., Namenwirth, M., & Yang, L. (2024) · Cells · doi:10.3390/cells13030236 · Cited by 29
Rajan, P., Natraj, P., Ranaweera, S. S., Dayarathne, L. A., Lee, Y. J., & Han, C. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112059 · Cited by 30
TSC22D4 interacts with Akt1 to regulate glucose metabolism
Demir, S., Wolff, G., Wieder, A., Maida, A., Bühler, L., Brune, M., Hautzinger, O., Feuchtinger, A., Poth, T., Szendroedi, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo5555 · Cited by 27
Ofosu‐Boateng, M., Shaik, F., Choi, S., Ekuban, F. A., Gebreyesus, L. H., Twum, E., Nnamani, D. O., Yeyeodu, S. T., Yadak, N., Collier, D. M., et al. (2024) · BioFactors · doi:10.1002/biof.2028 · Cited by 29
“35 The glucose transporter Glut2 helps maintain glucose homeostasis by controlling hepatic release of glucose during gluconeogenesis 36 ; however, reduced expression of both hepatic Glut2 and Glut4 genes by HFD in both sexes does not explain this HFD-induced glucose intolerance in male mice.”
BackgroundBhushan, R., Rani, A., Gupta, D., Ali, A., Tripathi, A., & Dubey, P. K. (2022) · MicroRNA · doi:10.2174/2211536611666220413100636 · Cited by 28
Nehmi, V. A., Murata, G. M., de Moraes, R. C. M., Lima, G. C. A., de Miranda, D. A., Radloff, K., Costa, R., de Jesus, J. D. C. R., de Freitas, J. A., Viana, N. I., et al. (2021) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2021.05.002 · Cited by 25
Santamarina, A. B., Mennitti, L. V., de Souza, E. A., Mesquita, L. M. D. S., Noronha, I. H., Vasconcelos, J. R., Prado, C. M., & Pisani, L. P. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.09.024 · Cited by 23
Yang, N., Tang, Q., Qin, W., Li, Z., Wang, D., Zhang, W., Cao, X., Lu, Y. Z., Ge, X., Sun, H., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.053 · Cited by 24
Ijaz, A., Babar, S., Sarwar, S., Shahid, S. U., & Shabana, S. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0459-1 · Cited by 23
Probing metabolic memory in the hepatic response to fasting
Defour, M., Hooiveld, G. J. E. J., van Weeghel, M., & Kersten, S. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00117.2020 · Cited by 24
“Important transcription factors and transcriptional coactivators involved in the adaptive response to fasting in liver are PPARa, Foxo1, CREB3L3, GR, CREB, PGC1a, and TFEB (4, 18, 19, 26).”
BackgroundPost‐translational regulation of PGC‐1α modulates fibrotic repair
Larson‐Casey, J. L., Gu, L., Davis, D., Cai, G., Ding, Q., He, C., & Carter, A. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100339r · Cited by 24
Comprehensive Analysis of the lncRNA–miRNA–mRNA Regulatory Network for Intramuscular Fat in Pigs
Zhao, Y., Chen, S., Yuan, J., Shi, Y., Wang, Y., Xi, Y., Qi, X., Guo, Y., Sheng, X., Liu, J., et al. (2023) · Genes · doi:10.3390/genes14010168 · Cited by 26
“The latter can activate phosphatidylinositol 3-kinase (PI3K), and activate ser/thr kinases phosphoinositide dependent protein kinase-1 (PDK1) and protein kinase B (also known as Akt), thereby stimulating fatty acid synthesis and inhibiting gluconeogenesis [63,64].”
BackgroundSantamarina, A. B., de Moraes, R. C. M., Filho, V. N., Murata, G. M., de Freitas, J. A., de Miranda, D. A., Cerqueira, A., Costa, S. K. P., Ferreira, A. F. F., Britto, L. R., et al. (2022) · Antioxidants · doi:10.3390/antiox11030447 · Cited by 23
“In contrast, IL-6 derived from hepatic macrophages was able to activate IRS-2, improve insulin sensitivity, and was upregulated by adiponectin gene expression [98].”
BackgroundWang, Y., Fan, M., Qian, H., Ying, H., Li, Y., & Wang, L. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2183382 · Cited by 20
Time Restricted Eating: A Valuable Alternative to Calorie Restriction for Addressing Obesity?
Parrotta, M. E., Colangeli, L., Scipione, V., Vitale, C., Sbraccia, P., & Guglielmi, V. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00609-z · Cited by 21
A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control
Ma, Y., Liu, S., Jun, H., Wang, J., Fan, X., Li, G., Yin, L., Rui, L., Weinman, S. A., Gong, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001061r · Cited by 20
Benzyl Butyl Phthalate Induced Early lncRNA H19 Regulation in C3H10T1/2 Stem Cell Line
Zhang, J., & Choudhury, M. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00129 · Cited by 20
Feng, C., Jiang, Y., Wu, G., Shi, Y., Ge, Y., Li, B., Cheng, X., Xue Ming, T. A. N. G., Zhu, J., & Le, G. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08373 · Cited by 19
Gao, X., Zhu, Z., Bao, Y., Li, Y., Zhu, W., He, X., Ge, X., Huang, W., Wang, H., Wei, W., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00950-w · Cited by 19
“The peroxisome proliferator-activated receptor γ coactivator 1-α (PGC1α), a transcriptional coactivator induced by fasting [19, 20], can bind with PPARα to form heterodimer to regulate the expression of genes involved in lipid metabolism [21].”
BackgroundIdentification of Potential miRNA‐mRNA Regulatory Network Contributing to Parkinson’s Disease
Yin, X., Wang, M., Wang, W., Chen, T., Song, G., Niu, Y., Jiang, Z., Gao, Z., & Wang, Z. (2022) · Parkinson s Disease · doi:10.1155/2022/2877728 · Cited by 18
“Interestingly, PGC-1αwas also reported to regulate the IRS2 level in hepatic metabolism [38].”
The application of procyanidins in diabetes and its complications: a review of preclinical studies
Zhang, Y., Li, M., Liu, H., Fan, Y., & Liu, H. H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1532246 · Cited by 29
Mollet, I. G., & Macedo, M. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043875 · Cited by 18
Liepinsh, E., Zvejniece, L., Clemensson, L. E., Ozola, M., Vavers, E., Cirule, H., Korzh, S., Skuja, S., Groma, V., Brīvība, M., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16363 · Cited by 16
Laker, R. C., Egolf, S., Will, S., Lantier, L., McGuinness, O. P., Brown, C. L., Bhagroo, N. V., Oldham, S. N., Kuszpit, K. K., Alfaro, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59773-4 · Cited by 18
“Here, speci fi c enhancement of hepatic AKT S473 phosphorylation, but not T308, with CI/VI and increased protein and gene expression of Irs2 , but not Irs1 by cota-dutide treatment supports this concept and complements previous observations 34 – 36 .”
Lee, R. A., Chang, M., Yiv, N., Tsay, A., Tian, S., Li, D., Poulard, C., Stallcup, M. R., Pufall, M. A., & Wang, J.-C. (2023) · Nature Communications · doi:10.1038/s41467-023-38584-5 · Cited by 16
“4c) have been shown to play a positive role in insulin sensitivity and the reduction of gluconeogenic gene expression 28,29 .”
InfluentialExercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD
Hari, A., Fealy, C. E., Axelrod, C. L., Haus, J. M., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002273 · Cited by 17
He, Y., Yang, X., He, X., Wang, G., Li, C., Yuan, P., & Li, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1589695 · Cited by 16
Jiang, Y., Wang, L., Fan, F., Fang, Q., Li, H., Wang, M., & Zhao, Y. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106385 · Cited by 15
Mármol‐Sánchez, E., Ramayo‐Caldas, Y., Quintanilla, R., Cardoso, T. F., González-Prendes, R., Tibau, J., & Amills, M. (2020) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0412-z · Cited by 16
Effects of Training Status and Exercise Mode on Global Gene Expression in Skeletal Muscle
Bizjak, D. A., Zügel, M., Treff, G., Winkert, K., Jerg, A., Hudemann, J., Mooren, F. C., Krüger, K., Niess, A. M., & Steinacker, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212578 · Cited by 17
“Upregulation of PGC-1α expression led to IRS1 down-regulation and IRS2 up-regulation in hepatic mouse cells [42].”
BackgroundShen, W., Wan, X., Hou, J., Liu, Z., Mao, G., Xu, X., Yu, C., Zhu, X., & Ju, Z. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac031 · Cited by 14
Manohar, S., Yu, Q., Gygi, S. P., & King, R. W. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002069 · Cited by 16
“We next analyzed the effect of IRS2 knockout on APC/C activity in cells expressing mAG1-geminin (1-101), an APC/C substrate that is stabilized by the spindle assembly checkpoint (53).”
BackgroundMethodInfluentialCorral‐Jara, K. F., Cantini, L., Poupin, N., Ye, T., Rigaudière, J., Vincent, S. D. S., Pinel, A., Morio, B., & Capel, F. (2020) · Nutrients · doi:10.3390/nu12123864 · Cited by 16
“The model was based on the observation that a high level of Pgc-1α expression during fasting shifts the ratio of Irs1:Irs2 toward a higher Irs2 expression to prime the insulin receptor response toward a more efficient inhibition of gluconeogenesis after feeding [30].”
BackgroundMethodInfluentialDifferential Roles of CD36 in Regulating Muscle Insulin Response Depend on Palmitic Acid Load
Sun, J., Su, Y., Chen, J., Qin, D., Xu, Y., Chu, H., Lu, T., Dong, J., Qin, L., & Li, W. (2023) · Biomedicines · doi:10.3390/biomedicines11030729 · Cited by 188
Liver metabolism: the pathways underlying glucose utilization and production
Nogueira‐Ferreira, R., Oliveira, P. F., & Ferreira, R. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91704-9.00018-5 · Cited by 16
Vardanyan, S., Brosig, A., Merz, H., Ranjbar, M., Kakkassery, V., Grisanti, S., & Tura, A. (2020) · Cancers · doi:10.3390/cancers12082101 · Cited by 13
Lou, P., Lucchinetti, E., Wawrzyniak, P., Morsy, Y., Wawrzyniak, M., Scharl, M. M., Krämer, S. D., Rogler, G., Hersberger, M., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000412 · Cited by 13
Characterization of LY3324954 a long-acting glucagon-receptor agonist
Roell, W. C., Coşkun, T., Kim, T., O’Farrell, L. S., Martin, J. A., Nason, S. R., Hernandez-Alamillo, J., Dhantu, S., Drucker, D. J., Sloop, K. W., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102073 · Cited by 12
“We and others have reported enhanced insulin sensitivity following glucagon or GCGR-agonism [29,30,32,33].”
InfluentialSari, A. R., Risdayanto, R. D., Pradipta, M. H., Qorni, U. A., Rejeki, P. S., Argarini, R., Halim, S., & Pranoto, A. (2024) · Retos · doi:10.47197/retos.v53.102429 · Cited by 14
Zheng, Y., Yao, M., Chen, S., Li, J., Wei, X., Qiu, Z., Chen, L., & Zhang, L. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119044 · Cited by 12
Molecular mechanisms involved in fetal programming and disease origin in adulthood
Aguayo-Guerrero, J. A., León‐Cabrera, S., & Escobedo, G. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0491 · Cited by 12
da Costa, C. S., de Oliveira, T. F., Santos, F. C. F. D., Padilha, A., Krause, M., Carneiro, M. T., Miranda-Alves, L., & Graceli, J. (2024) · Environmental Toxicology · doi:10.1002/tox.24306 · Cited by 9
Yu, H., Zhang, Y., Chen, J., Jiang, S., Zheng, Y., Xu, Y., Li, Y., Kong, J., Yu, X., & Du, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.039 · Cited by 10
Butaphosphan Effects on Glucose Metabolism Involve Insulin Signaling and Depends on Nutritional Plan
Weiller, M. A. A., Rincón, J. A. A., Jacometo, C. B., Barros, C. C., de Souza, I. C. C., Hax, L. T., da Silva, T. C., Mattei, P., Barbosa, A. A., Feijó, J. D. O., et al. (2020) · Nutrients · doi:10.3390/nu12061856 · Cited by 10
“A recent study showed that Ppargc1a influences the balance between IRS1 and IRS2 expression in liver cells, and as a result, the coactivator plays a key role in insulin-mediated control of gluconeogenesis during the fasting-to-fed transition [31].”
BackgroundAshiqueali, S., Zhu, X., Wiesenborn, D. S., Gesing, A., Schneider, A., Noureddine, S. A., Correa-Garcia, C. G., Masternak, M. M., & Siddiqi, S. A. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112506 · Cited by 9
Protective effect of oleuropein on the brain tissue in D-Galactose-induced aging in rat model
Hu, X., Zhao, N., Ranjbar, E., Foruozandeh, H., Nahal, A. S., Asadoola, Y., & Ahmadi, I. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10165-9 · Cited by 9
“PGC-1α, a transcriptional coactivator, is essential for cel - lular energy metabolism, regulating mitochondrial biogenesis, oxidative metabolism, and glucose homeostasis [49–51].”
Liu, C., Zhu, T., Zhang, J., Wang, J., Gao, F., Ou, Q., Jin, C., Xu, J., Zhang, J., Tian, H., et al. (2021) · IUBMB Life · doi:10.1002/iub.2544 · Cited by 10
Kim, T., Nason, S. R., ANTIPENKO, J. P., Finan, B., Shalev, A., DiMarchi, R. D., & Habegger, K. M. (2022) · Diabetes · doi:10.2337/db21-1018 · Cited by 12
Arora, M., Canová, N. K., Šopin, T., Pavlíková, Z., Kučera, T., Vacík, T., & Slanař, O. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177890 · Cited by 7
Kalkan, K. K., Şen, S., Narlı, B., Seymen, C. M., & Yılmaz, C. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08444-y · Cited by 7
“There is evidence that PGC-1α promoter activity is inhibited by insulin [38].”
BackgroundGowayed, M. A., Ali, L. M. A., Kamel, M. A. E.-N., Oriquat, G. A., Piñol, R., Millán, Á., & El-Tahan, R. A. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0136 · Cited by 7
An AMP‐activated protein kinase‐PGC‐1α axis mediates metabolic plasticity in glioblastoma
Sauer, B., Kueckelhaus, J., Lorenz, N. I., Bozkurt, S., Schulte, D., Weinem, J., Benzarti, M., Meiser, J., Urban, H., Villa, G., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70030 · Cited by 7
Wu, H., Yang, A., Stelloo, S., Roos, F. J. M., Morsche, R. H. M. T., Verkerk, A. H., Velez, M. V. L., Wingens, L., de Wilt, J. H. W., Sauerwein, R. W., et al. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.050883 · Cited by 7
Vidyadharan, V. A., Blesson, C. S., Tanchico, D., Betancourt, A., Smith, C., & Yallampalli, C. (2023) · Nutrients · doi:10.3390/nu15071568 · Cited by 8
Omidifar, A., Shirvani, H., Taheri, R. A., Gorgani-Firouzjae, S., Delfan, M., Kalaki-Jouybari, F., & Khakdan, S. (2021) · Sport Sciences for Health · doi:10.1007/s11332-021-00736-9 · Cited by 6
Tan, L., Chen, Z., Ruan, Y., & Xu, H. (2022) · Epigenetics · doi:10.1080/15592294.2022.2086675 · Cited by 6
“The PPARGC1A is a nuclear hormone receptor coactivator peroxisome that regulates gluconeogenesis, lipid metabolism, energy metabolism, and detoxification of reactive oxygen species produced by mitochondria [59,60].”
BackgroundSharma, R., Sahoo, B., Srivastava, A., & Tiwari, S. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30294 · Cited by 6
“Renal‐specific deletion of IRS2 was found to elevate glucose levels in mice, while PT‐ specific IRS1/2 double knockout mice resulted in impaired insulin signaling and upregulated gluconeogenic enzyme expression.(14,17,18) Moreover, Nakamura 2020, reported that Insulin promotes sodium transport but suppresses gluconeog…”
BackgroundAshiqueali, S., Hayslip, N., Chaudhari, D. S., Schneider, A., Zhu, X., Rubis, B., Seavey, C., Alam, M. T., Hussein, R., Noureddine, S. A., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01539-3 · Cited by 5
“The upregulation of genes such as Irs2 , Foxo1 , and Pgc1α in Ames dwarf mice suggests enhanced insulin sensitivity, mitochondrial function, and resistance to oxidative stress, contributing to their metabolic function and extended lifespan [85].”
Palma, J., Maciejewska, D., Zgutka, K., Piotrowska, K., Skonieczna‐Żydecka, K., & Stachowska, E. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106764 · Cited by 5
GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
Luo, X., Shi, X., Sun, Z., Xiao, J., Song, H., Guo, L., & Xu, X. Y. (2020) · BioMed Research International · doi:10.1155/2020/1454396 · Cited by 5
“Although hepatic PGC-1α is regarded as a powerfully detrimentally impacting blood glucose control by generating enzymes that drive gluconeogenesis [29, 30], research has shown that increased PGC-1α levels respond to insulin, counteracting uncontrolled glucose production through regulating the hepatic ratio of insulin…”
BackgroundParvalbumin protein controls inhibitory tone in the spinal cordPreprint
Qiu, H., Miraucourt, L. S., Petitjean, H., Davidova, A., Levesque-Damphousse, P., Estall, J. L., & Sharif‐Naeini, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.15.508019 · Cited by 5
Self-citationWang, H., Zhou, H., Jiang, H., Hu, Y., Li, T., & Duan, G. (2024) · Aquaculture Research · doi:10.1155/2024/8961174 · Cited by 7
Role of PGC-1α in the proliferation and metastasis of malignant tumors
Zhang, T., Zhao, S., & Gu, C. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10360-3 · Cited by 3
“In addition to its role in oxida - tive metabolism, PGC-1α also plays an important role in sugar metabolism by modulating the expression of genes associated with gluconeogenesis (Yoon et al. 2001 ; Herzig et al. 2001; Besse-Patin et al. 2019).”
Wang, Z., Wang, D., Liu, Y., Jian, Z., Wang, M., & Lin, H. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106376 · Cited by 4
Liver–pancreas communication in disease and drug development
Jia, Y., Zhu, Q., Pan, Q., Lu, G., & Xiao, J. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.018 · Cited by 3
“…hepatocyte signaling ( i.e. , binding to insulin receptor and activates the PI3K — Akt — mTORC1 signaling) or non-canonical effectors ( e.g. , FoxO1 regulation of fatty acid oxidation and fine-tuning IRS1/IRS2 ratio by peroxisome-proliferator-activated receptor-gamma coactivator-1) 141,142 .”
Lei, S., Peng, W., Wu, L., Yu, L., Wang, M., Li, Q., Deng, Y., Zhao, S., Huang, P., & Chen, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1442279 · Cited by 3
Bovee, C. E., Grandgenett, R. P., Trevino, M. B., Dutta, S. M., Peachee, S. J., Kopriva, S., Haider, F., Liu, S., Bhardwaj, G., Penniman, C. M., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf075 · Cited by 3
Абатуров, А. Е., & Нікуліна, А. О. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.3.2025.1545 · Cited by 3
Li, G., Tan, X., Zhang, B., Guan, L., Zhang, Y., Yin, L., Gao, M., Zhu, S., & Xu, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.641829 · Cited by 5
“PGC-1α can affect insulin resistance through regulating gluconeogenesis, lipid catabolism, and reactive oxygen species (Besse-Patin et al., 2019; Lv et al., 2019), while PGC-1β can regulate sterol regulatory element binding protein1c (SREBP-1c) mediated lipogenesis in T2DM (Shuldiner and McLenithan, 2004; Chen et al.”
BackgroundRajsfus, B. F., Júnior, J. X. D. N., Chichierchio, M. S., Todeschini, A. R., Oliveira, I. D. A., Borges, F. D. S., Barroso, S. P. C., Mohana‐Borges, R., Pereira, J. L., Zancan, P., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123729 · Cited by 3
Dwijayanti, D. R., Okuyama, T., Ishii, T., Mukai, E., & Nishizawa, M. (2020) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v10i1.675 · Cited by 4
“Because PGC-1α defines the precise insulin signal in hepatocytes in response to fasting and feeding, a reduction in PGC-1α is associated with hepatic insulin resistance [34,39].”
Background
Metadata
- Authors
- Besse-Patin, A., Jeromson, S., Levesque-Damphousse, P., Secco, B., Laplante, M., & Estall, J. L.
- Affiliations
- Institut de Recherches Cliniques de Montréal (IRCM), Montreal, QC, Canada H2W 1R7;
- Montreal Clinical Research Institute (CA)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Estall, Jennifer L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-02-15
- Volume
- 116
- Issue
- 10
- Pages
- 4285-4290
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6410797
- OpenAlex
- W2913974217
- Cited by
- 124
- References
- 46
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 20 · 2023: 17 · 2022: 12 · 2021: 21 · 2020: 22 · 2019: 3
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Gouvernement du Canada | Canadian Institutes of Health Research (SVB-145591)
- Fonds de Recherche du Québec - Santé (35208)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1α, IRS-1, insulin receptor substrate 2, insulin signaling, hepatic gluconeogenesis, fasting, glucagon signaling, CREB, Akt, glucose homeostasis, insulin resistance, hepatocytes, non-alcoholic fatty liver disease, type 2 diabetes, cyclic AMP
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Diabetes Mellitus, Type 2, Fasting, Female, Gene Expression Regulation, Glucagon, Gluconeogenesis, Glucose, Homeostasis, Humans, Insulin, Insulin Resistance, Liver, Liver Diseases, Male, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Hepatocytes, Models, Animal, Proto-Oncogene Proteins c-akt, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.